Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciliberto

Showing results (631-640 of 839) with videos related to

Pageof 84
Sort By:
Pharmacological Reports : PR|August 19, 2025
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria regionAntonio Fabiano, Caterina De Sarro, Domenico Frajia, et al.
International Journal of Molecular Sciences|December 11, 2022
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA ExplorationEriseld Krasniqi, Frauke Goeman, Claudio Pulito, et al.
Frontiers in Pharmacology|September 16, 2016
Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"Sabrina C Cecere, Sabrina Rossetti, Carla Cavaliere, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma modelsElisabetta Valentini, Giulia Gentile, Marta Di Martile, et al.
Journal of Surgical Oncology|February 22, 2023
A prognostic score from a multicentric retrospective analysis of patients affected by sarcoma with metachronous lung metastases undergoing metastasectomyFilippo Tommaso Gallina, Enrico Melis, Luca Bertolaccini, et al.
Frontiers in Pharmacology|December 8, 2016
Corrigendum: Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"Sabrina C Cecere, Sabrina Rossetti, Carla Cavaliere, et al.
Oncogenesis|February 16, 2020
microRNA-378a-5p iS a novel positive regulator of melanoma progressionMaria Grazia Tupone, Simona D'Aguanno, Marta Di Martile, et al.
Computational and Structural Biotechnology Journal|May 25, 2022
Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern trackingSara Donzelli, Ludovica Ciuffreda, Martina Pontone, et al.
Cancers|October 21, 2020
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 LockdownAlessandra Fabi, Patrizia Pugliese, Pina Tiziana Falbo, et al.
Scientific Reports|August 16, 2017
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expressionAnna Di Benedetto, Cristiana Ercolani, Marcella Mottolese, et al.
Pageof 84

Showing results (631-640 of 839) with videos related to

Sort By:
Pageof 84
Pharmacological Reports : PR|August 19, 2025
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria regionAntonio Fabiano, Caterina De Sarro, Domenico Frajia, et al.
International Journal of Molecular Sciences|December 11, 2022
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA ExplorationEriseld Krasniqi, Frauke Goeman, Claudio Pulito, et al.
Frontiers in Pharmacology|September 16, 2016
Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"Sabrina C Cecere, Sabrina Rossetti, Carla Cavaliere, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 8, 2026
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma modelsElisabetta Valentini, Giulia Gentile, Marta Di Martile, et al.
Journal of Surgical Oncology|February 22, 2023
A prognostic score from a multicentric retrospective analysis of patients affected by sarcoma with metachronous lung metastases undergoing metastasectomyFilippo Tommaso Gallina, Enrico Melis, Luca Bertolaccini, et al.
Frontiers in Pharmacology|December 8, 2016
Corrigendum: Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"Sabrina C Cecere, Sabrina Rossetti, Carla Cavaliere, et al.
Oncogenesis|February 16, 2020
microRNA-378a-5p iS a novel positive regulator of melanoma progressionMaria Grazia Tupone, Simona D'Aguanno, Marta Di Martile, et al.
Computational and Structural Biotechnology Journal|May 25, 2022
Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern trackingSara Donzelli, Ludovica Ciuffreda, Martina Pontone, et al.
Cancers|October 21, 2020
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 LockdownAlessandra Fabi, Patrizia Pugliese, Pina Tiziana Falbo, et al.
Scientific Reports|August 16, 2017
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expressionAnna Di Benedetto, Cristiana Ercolani, Marcella Mottolese, et al.
Pageof 84